Evidence Supporting the Current Management Guidelines for High-Grade Squamous Intraepithelial Lesion Cytology

Journal of Lower Genital Tract Disease

Volumn 8, Issue 2, 2004, Pages 139-146

  Padilla Paz, Luis A ^a   Carlson, Jay ^b   Twiggs, Leo B ^c   Lonky, Neal ^d   Crum, Christopher P ^e   Felix, Juan ^f   Hunter, Verda ^g   Krumholz, Burton ^h   Stewart Massad, L ⁱ   Benedet, J L ^j  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d KAISER PERMANENTE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f LAC USC MEDICAL CENTER   (United States)

^g Resource Center for Gynecol Oncol   (United States)

^h LONG ISLAND JEWISH MEDICAL CENTER   (United States)

ⁱ SOUTHERN ILLINOIS UNIVERSITY   (United States)

^j BRITISH COLUMBIA CANCER AGENCY   (Canada)

more..

Author keywords

Cytology; Evidenced based; Guidelines; HSIL

Indexed keywords

CANCER GRADING; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; PRACTICE GUIDELINE; REVIEW; UNITED STATES; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

EID: 16544375183     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/00128360-200404000-00010     Document Type: Review

References (56)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(Suppl 8):S4-66.
2. Wabinga H, Ramanakumar AV, Banura C, Luwaga A, Nambooze S, Parkin DM. Survival of cervix cancer patients in Kampala, Uganda: 1995-1997. Br J Cancer 2003;89:65-9.
3. http://www.cancer.gov/cancerinfo/wyntk/cervix. Accessed 6/28/03.
4. American Cancer Society. Cancer Facts and Figures 2002, pg. 5, http://www.cancer.org/docroot/content/CRI/content/ CRI_2_4_1X_What_are_the_key_statistics_for_cervical_cancer.
5. U.S. Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Alexandria, VA: International Medical, 1996. Accessed 6/28/03.
6. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2:342-50.
7. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT. HPV 16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J 1989;8:3905-10.
8. Einstein MH, Burk RD. Persistent human papillomaviral infection: definitions and clinical implications. Papillomavirus Rep 2001;12:119-23.
9. Wright TC, Kurman RJ. A critical review of the morphologic classification systems of preinvasive lesions of the cervix: the scientific basis for shifting the paradigm. Papillomavirus Rep 1994;5:175-82.
10. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. Developed and approved at the National Cancer Institute Workshop, Bethesda, Maryland, U.S.A., December 12-13, 1988. Acta Cytol 1989;33:567-74.
11. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
12. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-8.
13. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186-92.
14. Stoler MH, Schiffman M. Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001;285:1500-5.
15. Abulafia O, Pezzullo JC, Sherer DM. Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Pap smears: a quantitative survey. Gynecol Oncol 2003;90:137-44.
16. Coste J, Cochand-Priollet B, de Cremoux P, Le Gales C, Cartier I, Molinie V, et al. French Society of Clinical Cytology Study Group. Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening. BMJ 2003;326:733.
17. Lindau ST, Tomori C, Lyons T, Langseth L, Bennett CL, Garcia P. The association of health literacy with cervical cancer prevention knowledge and health behaviors in a multiethnic cohort of women. Am J Obstet Gynecol 2002;186:938-43.
18. Jones BA, Davey DD. Quality management in gynecologic cytology using interlaboratory comparison. Arch Pathol Lab Med 2000;124:672-81.
19. Weintraub J, Morabia A. Efficacy of a liquid-based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer. Diagn Cytopathol 2000;22:52-9.
20. Hutchinson ML, Zahniser DJ, Sherman ME, Herrero R, Alfaro M, Bratti MC, et al. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer 1999;87:48-55.
21. Pan Q, Belinson JL, Li L, Pretorius RG, Qiao YL, Zhang WH, et al. A thin-layer, liquid-based Pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study. Acta Cytol 2003;47:45-50.
22. Massad LS, Riester KA, Anastos KM, Fruchter RG, Palefsky JM, Burk RD, et al. Prevalence and predictors of squamous cell abnormalities in Pap smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr 1999;21:33-41.
23. Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia? Obstet Gynecol 1998;91:973-6.
24. Massad LS, Collins YC, Meyer PM. Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Gynecol Oncol 2001;82:516-22.
25. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. JAMA 1994;271:1866-9.
26. Ferris DG, Cox JT, Burke L, Litaker MS, Harper DM, Campion MJ, et al. Colposcopy quality control: establishing colposcopy criterion standards for the ALTS trial using cervigrams. J Lower Gen Tract Dis 1998;2:195-203.
27. Ferris DG, Waxman AG, Miller MD. Colposcopy and cervical biopsy educational training models. Fam Med 1994;26:30-5.
28. Brown FM, Faquin WC, Sun D, Crum CP, Cibas ES. LSIL biopsies after HSIL smears. Am J Clin Pathol 1999;112:765-8.
29. Chappatte OA, Byrne DL, Raju KS, Nayagam M, Kenney A. Histological differences between colposcopic-directed biopsy and loop excision of the transformation zone (LETZ). Gynecol Oncol 1991;43:46-50.
30. Milne DS, Wadehra V, Mennim D, Wagstaff TI. A prospective follow up study of women with colposcopically unconfirmed positive cervical smears. Br J Obstet Gynaecol 1999;106:38-41.
31. Grenko RT, Abendroth CS, Frauenhoffer EE, Ruggiero FM, Zaino RJ. Variance in the interpretation of cervical biopsy specimens obtained for atypical squamous cells of undetermined significance. Am J Clin Pathol 2000;114:735-40.
32. Joste NE, Rushing L, Granados R, Zitz JC, Genest DR, Crum CP, et al. Bethesda classification of cervicovaginal smears: reproducibility and viral correlates. Hum Pathol 1996;27:581-5.
33. Sellors JW, Nieminen P, Vesterinen E, Paavonen J. Observer variability in the scoring of colpophotographs. Obstet Gynecol 1990;76:1006-8.
34. Mitchell MF, Schottenfeld D, Tortolero-Luna G, Cantor SB, Richards-Kortum R. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998;91:626-31.
35. Myers ER, McCrory DC, Subramanian S, McCall N, Nanda K, Datta S, et al. Setting the target for a better cervical screening test: characteristics of a cost-effective test for cervical neoplasia screening. Obstet Gynecol 2000;96:645-52.
36. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000;151:1158-71.
37. Bigrigg A, Haffenden DK, Sheehan AL, Codling BW, Read MD. Efficacy and safety of large-loop excision of the transformation zone. Lancet 1994;343:32-4.
38. Denny LA, Soeters R, Dehaeck K, Bloch B. Does colposcopically directed punch biopsy reduce the incidence of negative LLETZ? Br J Obstet Gynaecol 1995;102:545-8.
39. Holschneider CH, Felix JC, Satmary W, Johnson MT, Sandweiss LM, Montz FJ. A single-visit cervical carcinoma prevention program offered at an inner city church: a pilot project. Cancer 1999;86:2659-67.
40. Santos C, Galdos R, Alvarez J, Velarde C, Barriga O, Dyer R, et al. One-session management of cervical intraepithelial neoplasia: a solution for developing countries. Gynecol Oncol 1996;61:11-5.
41. Bigrigg MA, Codling BW, Pearson P, Read MD, Swingler GR. Colposcopic diagnosis and treatment of cervical dysplasia at a single clinic visit. Lancet 1990;336:229-31.
42. Luesley DM, Cullimore J, Redman CWE, Lawton FG, Emens JM, Rollason TP, et al. Loop diathermy excision of the cervical transformation zone in patients with abnormal cervical smears. BMJ 1990;300:1690-3.
43. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. ASCCP-Sponsored Consensus Conference 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9.
44. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
45. Kish MA. Guide to development of practice guidelines. Clin Infect Dis 2001;32:851-4.
46. Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ, the American Society for Colposcopy and Cervical Pathology. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003;189:295-304.
47. Roberts CH, Dinh V, Hannigan EV, Yandell RB, Schnadig VJ. Management of cervical intraepithelial neoplasia during pregnancy: a simplified and cost-effective approach. J Lower Gen Tract Dis 1998;2:67-70.
48. Greer BE, Easterling TR, McLennan DA, Benedetti TJ, Cain JM, Figge DC, et al. Fetal and maternal considerations in the management of stage IB cervical cancer during pregnancy. Gynecol Oncol 1989;34:61-5.
49. Duggan B, Muderspach LI, Roman LD, Curtin JP, d'Ablaing G, Morrow CP. Cervical cancer in pregnancy: reporting on planned delay in therapy. Obstet Gynecol 1993;82:598-602.
50. Sorosky JI, Squatrito R, Ndubisi BU, Anderson B, Podczaski ES, Mayr N, et al. Stage I squamous cell cervical carcinoma in pregnancy: planned delay in therapy awaiting fetal maturity. Gynecol Oncol 1995;59:207-10.
51. Takuushi M, Moromizato H, Sakumoto K, Kanazawa K. Management of invasive carcinoma of the uterine cervix associated with pregnancy: outcome of intentional delay in treatment. Gynecol Oncol 2002;87:185-9.
52. Abitbol MM, Benjamin F, Gastillo N. Management of the abnormal cervical smear and carcinoma in situ of the cervix during pregnancy. Am J Obstet Gynecol 1973;117:904-8.
53. Benedet JL, Selke PA, Nickerson KG. Colposcopic evaluation of abnormal Pap smears in pregnancy. Am J Obstet Gynecol 1987;157:932-7.
54. Economos K, Perez Veridiano N, Delke I, Collado ML, Tancer ML. Abnormal cervical cytology in pregnancy: a 17-year experience. Obstet Gynecol 1993;81:915-8.
55. Woodrow N, Permezel M, Butterfield L, Rome R, Tan J, Quinn M. Abnormal cervical cytology in pregnancy. Aust N Z J Obstet Gynaecol 1998;38:161-5.
56. Lonky NM, Sadeghi M, Tsadik GW, Petitti D. The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results. Am J Obstet Gynecol 1999;181:560-6.